98%
921
2 minutes
20
Background: The association of insomnia in older patients with out-of-hospital cardiac arrest (OHCA) is not completely elucidated. The current study developed and validated a predictive model for OHCA in older patients using population-based analysis.
Methods: This study used data from the National Health Insurance research database. The cohort included older patients (aged more than 65 years) diagnosed with insomnia and treated with insomnia medications. The multivariate logistic regression model was used to analyze potential OHCA predictors. The model's performance was evaluated via internal and external validations using the receiver operating characteristic curve and confusion matrix indices.
Results: Of the 438,147 older patients with insomnia, 6,931 (1.6%) experienced OHCA. The key predictors included age, male sex, previous use of medical resources, treatment with hemodialysis, existing comorbidities, medication possession ratio, medication changes, and recent psychotherapy. The receiver operating characteristic curve values of the predictive models for 7-, 30-, and 90-day OHCA ranged from 0.757 to 0.787. The 2019 and 2020 external validation confirmed that the model was robust. The sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio of the 7-day model in 2019 were 0.781, 0.754, 2.78, 0.42, and 6.58, respectively. Meanwhile, the sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio of the 7-day model in 2020 were 0.731, 0.677, 2.27, 0.40, and 5.71, respectively.
Conclusions: This study developed a robust predictive model for OHCA among older patients with insomnia. The model was effective in identifying important predictors that could assist psychiatrists in recognizing high-risk individuals and enhancing preventive care.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329982 | PMC |
http://dx.doi.org/10.1186/s12877-025-06285-x | DOI Listing |
Oncologist
September 2025
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Background: Belzutifan is a HIF-2ɑ inhibitor approved for the treatment of tumors in von Hippel-Lindau (VHL) syndrome and sporadic metastatic clear cell renal cell carcinoma (spRCC) in the refractory setting. The efficacy and side effects of belzutifan are well-documented from clinical trials, however, real-world data examining the incidence and management of adverse events (AEs) are lacking. Our study aims to describe the AE profiles of belzutifan in spRCC and VHL populations.
View Article and Find Full Text PDFHead Neck Pathol
September 2025
Department of Laboratory Medicine and Pathology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA.
Myoepithelial carcinoma (MECA) is a malignant neoplasm composed exclusively of myoepithelial cells and accounts for less than 1% of all salivary gland tumors. Its diagnosis is often challenging due to histologic overlaps with benign lesions and its variable morphologic presentation. Although molecular profiling has emerged as a valuable tool in salivary gland tumor classification, the genetic landscape of MECA remains incompletely defined.
View Article and Find Full Text PDFInt Urogynecol J
September 2025
Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Introduction And Hypothesis: Aging may place patients at greater risk for adverse perioperative outcomes. We hypothesized that women undergoing minimally invasive (MIS) sacrocolpopexy aged ≥ 70 years are more likely to experience adverse events (AE) within 8 weeks of surgery.
Methods: We performed a secondary analysis of a retrospective study on perioperative adverse events in women ≥ 61 years old undergoing prolapse surgery at a single academic center from January 2016 to May 2023.
J Intensive Care Med
September 2025
Independent Researcher, Outcomes Research, Atlanta, GA, USA.
Purpose: Obesity is a risk factor for sepsis complications in older adults. We assessed the impact of metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUHO) on outcomes in septic shock.
Methods: We conducted a retrospective analysis using the National Inpatient Sample (2016-2020) to identify a cohort of 1,737,075 patients aged 65 years and older who were hospitalized with septic shock, as defined by ICD-10 diagnosis codes.
Osteoporos Int
September 2025
University of Alabama at Birmingham, Birmingham, AL, USA.
Unlabelled: Higher area socioeconomic level was associated with a decreased risk of romosozumab discontinuation during COVID-19 lockdown among U.S. Medicare beneficiaries.
View Article and Find Full Text PDF